Aligos Therapeutics, Inc. (ALGS) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2024 | $130.0K | +584.2% |
| 2023 | $19.0K | -98.0% |
| 2022 | $943.0K | +5.7% |
| 2021 | $892.0K | -56.8% |
| 2020 | $2.06M | -25.9% |
| 2019 | $2.79M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2024 | $130.0K | +584.2% |
| 2023 | $19.0K | -98.0% |
| 2022 | $943.0K | +5.7% |
| 2021 | $892.0K | -56.8% |
| 2020 | $2.06M | -25.9% |
| 2019 | $2.79M | — |